ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,436.20
-0.10%
S&P ASX All Technology
3,964.00
0.35%
Brent Oil
71.98
0.00%
US Dollar vs AUD
1.53421
0.00%
Bitcoin
96,545.10
0.11%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. MedTech Acquisition Corporation (MTAC)

  7. MedTech Acquisition Corporation (MTAC) News

MTAC

MedTech Acquisition (MTAC)

MedTech Acquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MTAC
DateTimeSourceHeadlineSymbolCompany
03/08/202307:00Business WireMedTech Acquisition Corporation Adjourns Special Meeting of StockholdersNASDAQ:MTACMedTech Acquisition Corporation
28/06/202306:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:MTACMedTech Acquisition Corporation
23/06/202307:07Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:MTACMedTech Acquisition Corporation
16/06/202307:14Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MTACMedTech Acquisition Corporation
16/06/202306:11Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
12/06/202321:06Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
12/06/202321:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
12/06/202321:00Business WireTriSalus Life Sciences Presents Additional Data for SD-101 Delivered by the Proprietary PEDD™ Method with the TriNav™ Device for Uveal Melanoma Liver Metastases at the ASCO 2023 Annual MeetingNASDAQ:MTACMedTech Acquisition Corporation
08/06/202321:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
08/06/202321:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
25/05/202306:29Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:MTACMedTech Acquisition Corporation
15/05/202321:01Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
15/05/202321:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
22/04/202307:12Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:MTACMedTech Acquisition Corporation
20/04/202321:07Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
20/04/202321:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
20/04/202321:00Business WireTriSalus Life Sciences Presents New Data at AACR for SD-101 Delivered by the Proprietary PEDD™ Method in Stage IV Uveal Melanoma Patients With Liver MetastasesNASDAQ:MTACMedTech Acquisition Corporation
06/04/202306:32Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
06/04/202306:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
23/03/202307:17Edgar (US Regulatory)Annual Report (10-k)NASDAQ:MTACMedTech Acquisition Corporation
09/03/202308:34Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
09/03/202308:31Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
21/02/202323:08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
21/02/202323:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
21/02/202323:00Business WireTriSalus Life Sciences Appoints James Alecxih to Lead Device Technology BusinessNASDAQ:MTACMedTech Acquisition Corporation
16/02/202323:08Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:MTACMedTech Acquisition Corporation
16/02/202323:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:MTACMedTech Acquisition Corporation
10/02/202309:29Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:MTACMedTech Acquisition Corporation
10/02/202301:24Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MTACMedTech Acquisition Corporation
09/02/202306:11Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:MTACMedTech Acquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:MTAC

Your Recent History

COIN
XRPUSD
Ripple
PM
XAUUSD
Gold vs US Dollar
ASX
SUN
Suncorp
ASX
TLS
Telstra
ASX
BHP
BHP
ASX
CSL
CSL
NASDAQ
MSFT
Microsoft
NASDAQ
TSLA
Tesla
SPI
SP500
S&P 500
NYSE
MCD
McDonalds
NYSE
JPM
JP Morgan Chase
ASX
WBC
Westpac Banking
ASX
FMG
Fortescue
NASDAQ
QQQ
Invesco QQQ Trust Series 1
ASX
WDC
Westfield
FX
EURAUD
Euro vs AUD
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36